Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Clinical Trial on the Effectiveness of the Flavonoids Genistein and Quercetin in Men With Rising Prostate-specific Antigen

Trial Profile

Clinical Trial on the Effectiveness of the Flavonoids Genistein and Quercetin in Men With Rising Prostate-specific Antigen

Status: Recruiting
Phase of Trial: Phase II

Latest Information Update: 07 Nov 2021

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Genistein (Primary) ; Quercetin (Primary)
  • Indications Prostate cancer
  • Focus Therapeutic Use
  • Acronyms QUERGEN

Most Recent Events

  • 24 Nov 2015 The recruitment status of this study is unknown because the information has not been verified recently (Verified on May 2012). Kept previous status as recruiting as per ClinicalTrials.gov record.
  • 08 May 2013 Interim results presented at the 108th Annual Meeting of the American Urological Association.
  • 18 Mar 2013 Interim results (n=18) presented at the 28th Congress of the European Association of Urology.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top